Items where Author is "Sallam, H"
Up a level |
Number of items: 5.
2011
Hassan, M;
Sallam, H;
Hassan, Z;
(2011)
The Role of Pharmacokinetics and Pharmacodynamics in Early Drug Development with reference to the Cyclin-dependent Kinase (Cdk) Inhibitor - Roscovitine.
Sultan Qaboos University medical journal, 11 (2).
pp. 165-78.
ISSN 2075-051X
http://researchonline.lshtm.ac.uk/id/eprint/694965
2009
Iurisci, I;
Filipski, E;
Sallam, H;
Harper, F;
Guettier, C;
Maire, I;
Hassan, M;
Iacobelli, S;
Lévi, F;
(2009)
Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclib.
Chronobiology international, 26 (6).
pp. 1169-88.
ISSN 0742-0528
DOI: https://doi.org/10.3109/07420520903209942
Full text not available from this repository.
2008
Bettayeb, K;
Sallam, H;
Ferandin, Y;
Popowycz, F;
Fournet, G;
Hassan, M;
Echalier, A;
Bernard, P;
Endicott, J;
Joseph, B;
+1 more...
Meijer, L;
(2008)
N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine.
Molecular cancer therapeutics, 7 (9).
pp. 2713-24.
ISSN 1535-7163
DOI: https://doi.org/10.1158/1535-7163.MCT-08-0080
Full text not available from this repository.
Sallam, H;
Jimenez, P;
Song, H;
Vita, M;
Cedazo-Minguez, A;
Hassan, M;
(2008)
Age-dependent pharmacokinetics and effect of roscovitine on Cdk5 and Erk1/2 in the rat brain.
Pharmacological research, 58 (1).
pp. 32-7.
ISSN 1043-6618
DOI: https://doi.org/10.1016/j.phrs.2008.05.010
Full text not available from this repository.
2007
Song, H;
Vita, M;
Sallam, H;
Tehranchi, R;
Nilsson, C;
Sidén, A;
Hassan, Z;
(2007)
Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
Cancer chemotherapy and pharmacology, 60 (6).
pp. 841-9.
ISSN 0344-5704
DOI: https://doi.org/10.1007/s00280-007-0431-x
Full text not available from this repository.